Note 8 - Stockholders' Deficit (Details 2) - USD ($) |
12 Months Ended | |
|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
|
| Allocated Share-based Compensation Expense | $ 255,000 | $ 40,000 |
| Research and Development Expense [Member] | ||
| Allocated Share-based Compensation Expense | 96,000 | 13,000 |
| General and Administrative Expense [Member] | ||
| Allocated Share-based Compensation Expense | $ 159,000 | $ 27,000 |
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|